Exact Sciences Stock Today
| EXAS Stock | USD 71.34 1.61 2.21% |
Performance1 of 100
| Odds Of DistressLess than 30
|
EXACT Sciences is selling for under 71.34 as of the 16th of April 2024; that is -2.21 percent decrease since the beginning of the trading day. The stock's lowest day price was 70.78. EXACT Sciences has about a 30 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for EXACT Sciences are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 17th of March 2024 and ending today, the 16th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of February 2001 | Category Healthcare | Classification Health Care |
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin. Exact Sciences operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. The company has 181.53 M outstanding shares of which 6.34 M shares are currently shorted by private and institutional investors with about 3.0 trading days to cover. More on EXACT Sciences
Moving against EXACT Stock
| 0.7 | REGN | Regeneron Pharmaceuticals Financial Report 2nd of May 2024 | PairCorr |
| 0.57 | HOWL | Werewolf Therapeutics Upward Rally | PairCorr |
| 0.57 | ABBV | AbbVie Inc Financial Report 25th of April 2024 | PairCorr |
| 0.53 | JNJ | Johnson Johnson Earnings Call Today | PairCorr |
| 0.47 | CCCC | C4 TherapeuticsInc Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
EXACT Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. EXACT Sciences' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding EXACT Sciences or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman | Kevin Conroy | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, ARCA Biotechnology, NASDAQ Health Care, NASDAQ Composite, NASDAQ Composite Total, Health Care, Biotechnology, Diagnostics & Research, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering EXACT Sciences report their recommendations after researching EXACT Sciences' financial statements, talking to executives and customers, or listening in on EXACT Sciences' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering EXACT Sciences. The EXACT consensus assessment is calculated by taking the average forecast from all of the analysts covering EXACT Sciences. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to EXACT Sciences' liquidity, profitability, solvency, and operating efficiency, EXACT Sciences is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of EXACT Sciences is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EXACT Sciences' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to EXACT Sciences' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. EXACT Sciences' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of EXACT Sciences' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest. Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand EXACT Sciences' financial leverage. It provides some insight into what part of EXACT Sciences' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EXACT Sciences (EXAS) is traded on NASDAQ Exchange in USA. It is located in 5505 Endeavor Lane, Madison, WI, United States, 53719 and employs 6,500 people. EXACT Sciences is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.96 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate EXACT Sciences's market, we take the total number of its shares issued and multiply it by EXACT Sciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. EXACT Sciences conducts business under Biotechnology sector and is part of Health Care industry. The entity has 181.53 M outstanding shares of which 6.34 M shares are currently shorted by private and institutional investors with about 3.0 trading days to cover.
EXACT Sciences currently holds about 728.04 M in cash with 156.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.11.
Check EXACT Sciences Probability Of Bankruptcy
Ownership AllocationEXACT Sciences shows a total of 181.53 Million outstanding shares. The majority of EXACT Sciences outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to obtain positions in EXACT Sciences to benefit from reduced commissions. Thus, outside corporations are subject to a different set of regulations than regular investors in EXACT Sciences. Please pay attention to any change in the institutional holdings of EXACT Sciences as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check EXACT Ownership Details
EXACT Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of EXACT Sciences jumping above the current price in 90 days from now is about 6.03%. The EXACT Sciences probability density function shows the probability of EXACT Sciences stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days EXACT Sciences has a beta of 0.0745 suggesting as returns on the market go up, EXACT Sciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding EXACT Sciences will be expected to be much smaller as well. Additionally, eXACT Sciences has an alpha of 0.06, implying that it can generate a 0.06 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of EXACT Sciences to move above the current price in 90 days from now is about 6.03 (This EXACT Sciences probability density function shows the probability of EXACT Stock to fall within a particular range of prices over 90 days) .
EXACT Stock Institutional Holders
Institutional Holdings refers to the ownership stake in EXACT Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of EXACT Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing EXACT Sciences' value.| Instituion | Recorded On | Shares | |
| Ameriprise Financial Inc | 2023-12-31 | 2.5 M | |
| Sumitomo Mitsui Trust Holdings Inc | 2023-12-31 | 2.2 M | |
| Amvescap Plc. | 2023-12-31 | 2.2 M | |
| Allspring Global Investments Holdings, Llc | 2023-12-31 | 1.9 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 1.8 M | |
| Nikko Asset Management Americas Inc | 2023-12-31 | 1.8 M | |
| Citadel Advisors Llc | 2023-09-30 | 1.7 M | |
| Norges Bank | 2023-12-31 | 1.6 M | |
| Ensign Peak Advisors Inc | 2023-12-31 | 1.5 M | |
| Vanguard Group Inc | 2023-12-31 | 17.6 M | |
| Jpmorgan Chase & Co | 2023-12-31 | 16.7 M |
EXACT Sciences Historical Income Statement
EXACT Sciences Income Statement is one of the three primary financial statements used for reporting EXACT's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of EXACT Sciences revenue and expense. EXACT Sciences Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, EXACT Sciences' Cost Of Revenue is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 77.9 M in 2024, despite the fact that EBIT is likely to grow to (208.8 M). View More FundamentalsEXACT Stock Against Markets
Picking the right benchmark for EXACT Sciences stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in EXACT Sciences stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for EXACT Sciences is critical whether you are bullish or bearish towards EXACT Sciences at a given time. Please also check how EXACT Sciences' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in EXACT Sciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
| All Next | Launch Module |
EXACT Sciences Corporate Directors
EXACT Sciences corporate directors refer to members of an EXACT Sciences board of directors. The board of directors generally takes responsibility for the EXACT Sciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of EXACT Sciences' board members must vote for the resolution. The EXACT Sciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Katherine Napier | Independent Director | Profile | |
| Sally Crawford | Independent Director | Profile | |
| James Doyle | Independent Director | Profile | |
| Thomas Carey | Independent Director | Profile |
How to buy EXACT Stock?
Before investing in EXACT Sciences, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in EXACT Sciences. To buy EXACT Sciences stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of EXACT Sciences. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase EXACT Sciences stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located EXACT Sciences stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased EXACT Sciences stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as EXACT Sciences, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.
Already Invested in EXACT Sciences?
The danger of trading EXACT Sciences is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of EXACT Sciences is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than EXACT Sciences. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile EXACT Sciences is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether EXACT Sciences is a strong investment it is important to analyze EXACT Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EXACT Sciences' future performance. For an informed investment choice regarding EXACT Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EXACT Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. For more information on how to buy EXACT Stock please use our How to Invest in EXACT Sciences guide.Note that the EXACT Sciences information on this page should be used as a complementary analysis to other EXACT Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for EXACT Stock analysis
When running EXACT Sciences' price analysis, check to measure EXACT Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EXACT Sciences is operating at the current time. Most of EXACT Sciences' value examination focuses on studying past and present price action to predict the probability of EXACT Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EXACT Sciences' price. Additionally, you may evaluate how the addition of EXACT Sciences to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is EXACT Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EXACT Sciences. If investors know EXACT will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EXACT Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.13) | Revenue Per Share 13.876 | Quarterly Revenue Growth 0.17 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of EXACT Sciences is measured differently than its book value, which is the value of EXACT that is recorded on the company's balance sheet. Investors also form their own opinion of EXACT Sciences' value that differs from its market value or its book value, called intrinsic value, which is EXACT Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EXACT Sciences' market value can be influenced by many factors that don't directly affect EXACT Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EXACT Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if EXACT Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EXACT Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.